{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:23:10Z","timestamp":1781580190291,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40292-021-00437-x","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T16:00:09Z","timestamp":1613750409000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of Sacubitril\u2013Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9978-7875","authenticated-orcid":false,"given":"Pere","family":"Pericas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-3632","authenticated-orcid":false,"given":"Caterina","family":"Mas-Llad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1335-935X","authenticated-orcid":false,"given":"Maria Francisca","family":"Ramis-Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-1287","authenticated-orcid":false,"given":"Isabel","family":"Valadr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-3918","authenticated-orcid":false,"given":"Marta","family":"Noris Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-6132","authenticated-orcid":false,"given":"Luc\u00eda","family":"Pasamar M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gonz\u00e1lez Colino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco","family":"Forteza Albert\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0379-5243","authenticated-orcid":false,"given":"Vicente","family":"Peral Disdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-8463","authenticated-orcid":false,"given":"Xavier","family":"Rossello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/ejhf.1585","volume":"21","author":"J Tromp","year":"2019","unstructured":"Tromp J, Ferreira JP, Janwanishstaporn S, Shah M, Greenberg B, Zannad F, Lam C. Heart failure around the world. Eur J Heart Fail. 2019;21:1187\u201396.","journal-title":"Eur J Heart Fail"},{"key":"437_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10741-019-09829-7","volume":"25","author":"P Pellicori","year":"2020","unstructured":"Pellicori P, Khan MJI, Graham FJ, Cleland JGF. New perspectives and future directions in the treatment of heart failure. Heart Fail Rev. 2020;25:147\u201359.","journal-title":"Heart Fail Rev"},{"key":"437_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349\u201355.","journal-title":"N Engl J Med"},{"key":"437_CR4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","unstructured":"The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429\u201335.","journal-title":"N Engl J Med"},{"key":"437_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709\u201317.","journal-title":"N Engl J Med"},{"key":"437_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00392-018-1378-0","volume":"108","author":"X Rossello","year":"2019","unstructured":"Rossello X, Ariti C, Pocock SJ, Joao PF, Girerd N, McMurray JJV, Van Veldhuisen DJ, Pitt B, Zannad F. Impact of mineralocorticoid receptor antagonist on the risk of sudden cardiac death in patients with heart failure ant left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials. Clin Res Cardiol. 2019;108:477\u201386.","journal-title":"Clin Res Cardiol"},{"key":"437_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004.","journal-title":"N Engl J Med"},{"key":"437_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/03007995.2019.1576481","volume":"35","author":"ER Consentino","year":"2019","unstructured":"Consentino ER, Esposti DD, Miceli R, Bentivenga C, Landolfo M, Cicero AFG, Berardi E, Spinardi L, Magri G, Dugato V, Borghi C. Sacubitril\/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction. Curr Med Res Opin. 2019;35:9\u201312.","journal-title":"Curr Med Res Opin"},{"key":"437_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10557-019-06858-0","volume":"33","author":"C Moliner-Arb\u00f3s","year":"2019","unstructured":"Moliner-Arb\u00f3s C, Rivas-Lasarte M, Pamies Besora J, Fluvi\u00e0-Brugues P, Sol\u00e9-Gonz\u00e1lez E, Mirabet S, L\u00f3pez L\u00f3pez L, Brossa V, Pirla MJ, Mesado N, \u00c1lvarez-Garc\u00eda J, Roig E. Sacubitril\u2013Valsartan in real-life practice: experience in patients with advanced heart failure and systematic review. Cardiovasc Drugs Ther. 2019;33:307\u201314.","journal-title":"Cardiovasc Drugs Ther"},{"key":"437_CR10","first-page":"108","volume":"7","author":"A Almufleh","year":"2017","unstructured":"Almufleh A, Marbach J, Chih S, Stadnick E, Davies R, Liu P, Mielniczuk L. Ejection fraction improvement and reverse remodeling achieved with sacubitril\/valsartan in heart failure with reduced ejection fraction patients. Am J Cardiovasc Dis. 2017;7:108\u201313.","journal-title":"Am J Cardiovasc Dis"},{"key":"437_CR11","doi-asserted-by":"publisher","first-page":"e12435","DOI":"10.1111\/1755-5922.12435","volume":"36","author":"P Martens","year":"2018","unstructured":"Martens P, Beli\u00ebn H, Dupont M, Vandervoort P, Mullens W. The reverse remodeling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction. Cardiovasc Ther. 2018;36:e12435.","journal-title":"Cardiovasc Ther"},{"key":"437_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2019.12821","volume":"322","author":"JL Januzzi Jr","year":"2019","unstructured":"Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Pi\u00f1a IL, Rocha RA, Shah AM, Williamson KM, Solomon SD. Association of change in N-terminal Pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA. 2019;322:1\u201311.","journal-title":"JAMA"},{"key":"437_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijcard.2018.03.093","volume":"271","author":"Z Khan","year":"2018","unstructured":"Khan Z, Gholkar G, Tolia S, Kado H, Zughaib M. Effect of sacubitril\/valsartan on cardiac filling pressures in patients with left ventricular systolic dysfunction. Int J Cardiol. 2018;271:169\u201373.","journal-title":"Int J Cardiol"},{"key":"437_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors A, Anker S, Bueno H, Cleland JGF, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"437_CR15","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137-161.","journal-title":"Circulation"},{"key":"437_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"R Lang","year":"2015","unstructured":"Lang R, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1\u201339.","journal-title":"J Am Soc Echocardiogr"},{"key":"437_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"437_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jcmg.2016.08.014","volume":"10","author":"A Singh","year":"2017","unstructured":"Singh A, Addetia K, Maffessanti F, Mor-Avi V, Lang RM. LA strain categorization of LV diastolic dysfunction. JACC Cardiovasc Imaging. 2017;10:735\u201343.","journal-title":"JACC Cardiovasc Imaging"},{"key":"437_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","volume":"139","author":"DH Kang","year":"2019","unstructured":"Kang DH, Park SJ, Shin SH, Hong GR, Lee S, Kim MS, Yun SC, Song JM, Park SW, Kim JJ. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation. 2019;139:1354\u201365.","journal-title":"Circulation"},{"key":"437_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/ERP-18-0013","volume":"5","author":"E Worley","year":"2018","unstructured":"Worley E, Rana B, Williams L, Robinson S. Left ventricular diastolic dysfunction: identifying presence by left atrial function. Echo Res Pract. 2018;5:97\u2013104.","journal-title":"Echo Res Pract"},{"key":"437_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40292-017-0194-3","volume":"24","author":"ML Muiesan","year":"2017","unstructured":"Muiesan ML, Paini A, Agabiti Rosei C, Bertacchini F, Stassaldi D, Salvetti M. Current pharmacological therapies in heart failure patients. High Blood Press Cardiovasc Prev. 2017;24:107\u201314.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"437_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","volume":"133","author":"SA Hubers","year":"2016","unstructured":"Hubers SA, Brown NJ. Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation. 2016;133:1115\u201324.","journal-title":"Circulation"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-021-00437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-021-00437-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-021-00437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T11:25:13Z","timestamp":1615461913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-021-00437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s40292-021-00437-x","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Clinical Research Ethics Committee of our hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients provided written informed consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"All authors had full access to all the data in the study and takes responsibility for its integrity and the data analysis. The authors declare that all data is available within the article.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"PP: conceptualization, methodology, validation, data curation, writing-original draft, writing-review & editing, supervision; CM-L: formal analysis, validation, data curation, writing-original draft, writing-review & editing; MFR-B: data curation, visualization; IV: data curation, visualization; MNM: data curation, visualization; LPM: data curation, visualization; RGC: data curation, visualization; JFFA: data curation, visualization; VPD: visualization; XR: methodology, validation, formal analysis, writing-review & editing, supervision.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}